Doe
Wed, Jun-02-04, 06:17
It seems iron accumulation destroys beta cells leading to ..
diabetes .. Jeez .. have we heard of that somewhere ..
before ..?
J Clin Invest. 2003 Aug;112(4):527-34. Related Articles, Links
Frataxin deficiency in pancreatic islets causes diabetes due
to loss of beta cell mass.
Ristow M, Mulder H, Pomplun D, Schulz TJ, Muller-Schmehl
K, Krause A, Fex M, Puccio H, Muller J, Isken F, Spranger
J, Muller-Wieland D, Magnuson MA, Mohlig M, Koenig M,
Pfeiffer AF.
German Institute of Human Nutrition, Department Klinische
Ernahrung, 114 Arthur-Scheunert-Strasse, D-14558
Bergholz-Rehbrucke, Germany. mristow@mristow.org
Diabetes is caused by an absolute (type 1) or relative (type
2) deficiency of insulin-producing beta cells. We have
disrupted expression of the mitochondrial protein frataxin
selectively in pancreatic beta cells. Mice were born healthy
but subsequently developed impaired glucose tolerance
progressing to overt diabetes mellitus. These observations
were explained by impairment of insulin secretion due to a
loss of beta cell mass in knockout animals. This phenotype was
preceded by elevated levels of reactive oxygen species in
knockout islets, an increased frequency of apoptosis, and a
decreased number of proliferating beta cells. Hence,
disruption of the frataxin gene in pancreatic beta cells
causes diabetes following cellular growth arrest and
apoptosis, paralleled by an increase in reactive oxygen
species in islets. These observations might provide insight
into the deterioration of beta cell function observed in
different subtypes of diabetes in humans.
PMID: 12925693 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------
-------------
------
Expert Opin Investig Drugs 2003 Feb;12(2):235-245
Friedreich's ataxia: iron chelators that target the
mitochondrion as a therapeutic strategy?
Richardson D Iron Metabolism and Chelation Program, Children's
Cancer Institute Australia for Medical Research, High St (PO
Box 81), Randwick, Sydney, New South Wales, 2031, Australia.
d.richardson@ccia.org.au
[Record supplied by publisher]
Friedreich's ataxia (FA) is a severe inherited spinocerebellar
ataxia that primarily affects the nervous system and heart
leading to early confinement in a wheelchair and death. The
gene defective in FA, FRDA, encodes a mitochondrial protein
known as frataxin.( )A triplet repeat expansion within intron
1 of the FRDA gene results in a marked decrease in frataxin
expression. Over the last 5 years it has become clear that
this results in mitochondrial iron accumulation that generates
oxidative stress and results in damage to critical biological
molecules. Drugs that reduce oxidative stress have a limited
effect on the progression and pathology of the disease,
probably because these agents cannot remove the iron
accumulation. In this review, the potential of iron chelators,
namely the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone
(PCIH) analogues, as agents to remove mitochondrial iron
deposits is discussed. These ligands have been specifically
designed to enter and target mitochondrial iron pools, which
is a property lacking in desferrioxamine, the only chelator in
widespread clinical use. This latter drug may not have any
beneficial effect in FA patients, probably because of its
hydrophilicity that prevents mitochondrial access. Indeed,
standard chelation regimens will probably not work in FA, as
these patients do not exhibit gross iron-loading. Considering
that there is no effective treatment for FA, it is essential
that the therapeutic potential of iron chelators that target
mitochondrial iron pools is assessed experimentally.
PMID: 12556217
--------------------------------------------------------------
-------------
------
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com Man
Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore DEAD
PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
diabetes .. Jeez .. have we heard of that somewhere ..
before ..?
J Clin Invest. 2003 Aug;112(4):527-34. Related Articles, Links
Frataxin deficiency in pancreatic islets causes diabetes due
to loss of beta cell mass.
Ristow M, Mulder H, Pomplun D, Schulz TJ, Muller-Schmehl
K, Krause A, Fex M, Puccio H, Muller J, Isken F, Spranger
J, Muller-Wieland D, Magnuson MA, Mohlig M, Koenig M,
Pfeiffer AF.
German Institute of Human Nutrition, Department Klinische
Ernahrung, 114 Arthur-Scheunert-Strasse, D-14558
Bergholz-Rehbrucke, Germany. mristow@mristow.org
Diabetes is caused by an absolute (type 1) or relative (type
2) deficiency of insulin-producing beta cells. We have
disrupted expression of the mitochondrial protein frataxin
selectively in pancreatic beta cells. Mice were born healthy
but subsequently developed impaired glucose tolerance
progressing to overt diabetes mellitus. These observations
were explained by impairment of insulin secretion due to a
loss of beta cell mass in knockout animals. This phenotype was
preceded by elevated levels of reactive oxygen species in
knockout islets, an increased frequency of apoptosis, and a
decreased number of proliferating beta cells. Hence,
disruption of the frataxin gene in pancreatic beta cells
causes diabetes following cellular growth arrest and
apoptosis, paralleled by an increase in reactive oxygen
species in islets. These observations might provide insight
into the deterioration of beta cell function observed in
different subtypes of diabetes in humans.
PMID: 12925693 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------
-------------
------
Expert Opin Investig Drugs 2003 Feb;12(2):235-245
Friedreich's ataxia: iron chelators that target the
mitochondrion as a therapeutic strategy?
Richardson D Iron Metabolism and Chelation Program, Children's
Cancer Institute Australia for Medical Research, High St (PO
Box 81), Randwick, Sydney, New South Wales, 2031, Australia.
d.richardson@ccia.org.au
[Record supplied by publisher]
Friedreich's ataxia (FA) is a severe inherited spinocerebellar
ataxia that primarily affects the nervous system and heart
leading to early confinement in a wheelchair and death. The
gene defective in FA, FRDA, encodes a mitochondrial protein
known as frataxin.( )A triplet repeat expansion within intron
1 of the FRDA gene results in a marked decrease in frataxin
expression. Over the last 5 years it has become clear that
this results in mitochondrial iron accumulation that generates
oxidative stress and results in damage to critical biological
molecules. Drugs that reduce oxidative stress have a limited
effect on the progression and pathology of the disease,
probably because these agents cannot remove the iron
accumulation. In this review, the potential of iron chelators,
namely the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone
(PCIH) analogues, as agents to remove mitochondrial iron
deposits is discussed. These ligands have been specifically
designed to enter and target mitochondrial iron pools, which
is a property lacking in desferrioxamine, the only chelator in
widespread clinical use. This latter drug may not have any
beneficial effect in FA patients, probably because of its
hydrophilicity that prevents mitochondrial access. Indeed,
standard chelation regimens will probably not work in FA, as
these patients do not exhibit gross iron-loading. Considering
that there is no effective treatment for FA, it is essential
that the therapeutic potential of iron chelators that target
mitochondrial iron pools is assessed experimentally.
PMID: 12556217
--------------------------------------------------------------
-------------
------
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com Man
Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore DEAD
PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking